TRACON Pharmaceuticals Inc (TCON)
1.86
+0.05
(+2.76%)
USD |
NASDAQ |
May 03, 16:00
1.86
0.00 (0.00%)
After-Hours: 20:00
TRACON Pharmaceuticals Shareholders Equity (Quarterly): -0.809M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.809M |
| September 30, 2023 | -3.084M |
| June 30, 2023 | -15.74M |
| March 31, 2023 | -11.07M |
| December 31, 2022 | -7.151M |
| September 30, 2022 | -2.635M |
| June 30, 2022 | 2.542M |
| March 31, 2022 | 2.79M |
| December 31, 2021 | 11.71M |
| September 30, 2021 | 18.86M |
| June 30, 2021 | 11.92M |
| March 31, 2021 | 20.36M |
| December 31, 2020 | 25.07M |
| September 30, 2020 | 15.49M |
| June 30, 2020 | 3.003M |
| March 31, 2020 | 2.784M |
| December 31, 2019 | 2.698M |
| September 30, 2019 | 4.035M |
| June 30, 2019 | 8.919M |
| March 31, 2019 | 14.80M |
| Date | Value |
|---|---|
| December 31, 2018 | 21.44M |
| September 30, 2018 | 28.56M |
| June 30, 2018 | 36.96M |
| March 31, 2018 | 42.49M |
| December 31, 2017 | 16.99M |
| September 30, 2017 | 21.82M |
| June 30, 2017 | 17.30M |
| March 31, 2017 | 22.99M |
| December 31, 2016 | 28.34M |
| September 30, 2016 | 17.78M |
| June 30, 2016 | 18.09M |
| March 31, 2016 | 25.32M |
| December 31, 2015 | 30.98M |
| September 30, 2015 | 41.06M |
| June 30, 2015 | 46.79M |
| March 31, 2015 | 49.17M |
| December 31, 2014 | -32.17M |
| September 30, 2014 | -29.65M |
| December 31, 2013 | -25.34M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-15.74M
Minimum
Jun 2023
25.07M
Maximum
Dec 2020
4.720M
Average
2.79M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| BioSig Technologies Inc | -2.913M |
| Revolution Medicines Inc | 1.826B |
| Perspective Therapeutics Inc | 75.18M |
| Electromed Inc | 40.34M |
| Xtant Medical Holdings Inc | 51.35M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.10M |
| Total Liabilities (Quarterly) | 10.91M |
| Current Ratio | 0.8928 |
| Net Debt Paydown Yield | 23.47% |